Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory

Comparably Awards

Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions read more

This company is accepting feedback from verified employees EMPLOYEE PARTICIPANTS: 90

TOTAL RATINGS: 2628

CEO: Richard Paulson

eNPS at Karyopharm Therapeutics

Karyopharm Therapeutics' Employee Net Promoter Score (eNPS) is 10, as rated by 90 employees. Employee Net Promoter Score tracks Karyopharm Therapeutics employees' answers to this question: On a scale from 0-10, how likely are you to recommend working at Karyopharm Therapeutics to a friend? Today, 38% of Karyopharm Therapeutics employees would encourage their friends to become coworkers, whereas 34% are neutral and 28% would not recommend working at Karyopharm Therapeutics to their friends.

Last updated months ago.

Where This Score Ranks Karyopharm Therapeutics' eNPS

TOP
50%
In the Top 50% of 1671 Similar Sized Companies on Comparably
BOTTOM
45%
In the Bottom 45% of 231 Nearby Companies in Boston
5th
5th place versus 5 competitors rated on Comparably

Nov

Feb

Mar

May

Jun

Jan

Promoters
Passives
Detractors

Who Ranks Karyopharm Therapeutics' eNPS the Highest?

Department - Legal 67/100

Department - Marketing 40/100

Department - Research & Development 33/100

Who Ranks Karyopharm Therapeutics' eNPS the Lowest?

Ethnicity - Other -33/100

Department - Medical Affairs/HEOR -28/100

Department - Clinical Operations -15/100

Karyopharm Therapeutics eNPS At a Glance

Karyopharm Therapeutics employees are more likely to recommend Karyopharm Therapeutics as a great place to work. The employee Net Promoter Score is a simple way to measure loyalty and an employee's willingness to recommend working at their company to friends.

The Legal department and the Marketing department provided the highest scores when answering the question, “On a scale from 0-10, how likely are you to recommend working at Karyopharm Therapeutics to a friend?” Based on 90 ratings, Karyopharm Therapeutics ranks 5th place versus its 5 competitors and is right below Amgen.

Compared to other companies in Boston, Karyopharm Therapeutics falls into the Bottom 45% of 231 companies. The last rating was provided months ago.